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PrEP – Pre-Exposure Prophylaxis 
PSY – Psychosocial (complexity domain; CCRS-HIV) 
PTSD - Posttraumatic Stress Disorder 
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QA/QI - Quality Assurance/Quality Improvement 
QoL - Quality of Life 
SESLHD - South East Sydney Local Health District; a local health district (LHD) within NSW 
Health 
SMI - Severe Mental Illness 
STI - Sexually Transmitted Infection 
T Cells - Lymphocyte developed in the thymus gland, central to the immune response, and 
implicated in HIV-infection 
TAFE - Technical and Further Education Institutes; Tertiary educational facilities in Australia 
TasP - Treatment as prevention 
TB - Tuberculosis 
U.K. - United Kingdom 
U.S. - United States of America 
U=U - Undetectable = Untransmissable 
UDVL - Undetectable Viral Load 
UNAIDS - Joint United Nations Program on HIV/AIDS 
UTS - University of Technology Sydney 
Viraemia - The presence of virus in the blood 
VL - Viral Load 





Significant advances in the medical management of HIV have heralded a new era of 
treatment which acknowledges psychosocial, as well as medical, comorbidity factors. 
However, policy guidelines, reporting requirements and directives are yet to be revised 
accordingly, with metrics for successful treatment continuing to be considered in 
medical terms alone. The importance of medical and/or psychosocial comorbidity in 
impacting well-being, quality of life, and optimal holistic HIV management has arguably 
been under-represented in reporting outcomes. 
 
At present, biomedical markers such as viral load are used to measure treatment 
‘success’. Optimal holistic care should transcend viral load alone and include other 
measures such as overall functioning and health-related quality of life. Retention in 
care is a current metric within the HIV Care and Treatment Cascade, and the only one 
which allows for holistic monitoring or medical review by HIV specialists; however, at 
present, its full potential is not realised. Consistent definitions and means to measure 
retention are elusive, with differences within and between regions making 
comparisons difficult. However, retention remains an important component of the 
Cascade, as it affords the opportunity for optimal monitoring and timely intervention 
for biopsychosocial comorbidities which may ultimately impact disease progression 




In the context of three key theoretical models (the Biopsychosocial Model, the 
Syndemic Model, and the Andersen Behavioral Model of Health Service Use), the 
present study series aims to review current definitions of retention in HIV care and 
understand its specific antecedents through a series of four empirical studies. A 
systematic literature review considers the global literature on the subject, while a local 
qualitative analysis of both clinician and client perspectives provides context within the 
Australian public health landscape. A third study describing the development of an HIV 
client complexity rating scale, to assess for comorbidity, is outlined. These results are 
then used to assess the impact on retention in an Australian cohort of people living 
with HIV, in the fourth and final study. 
 
Results suggest a complex interplay of individual and contextual biological, 
psychological and social factors which impact retention in HIV care. Further, they 
suggest that particular interactions, or syndemics, beyond biomedical markers alone 
are implicated in poor retention in HIV care. 
 
The results are discussed in the context of appropriate theoretical models to 
understand the factors and the nature of the relationships between them. Implications 
for future research, as well as policy and reporting guidelines, are discussed. 
 
 
